C+79/100
Desk Score
Dispatch #7Editorial
Found
Aggressive identical pricing on both molecules, wrapped in a coaching-first program.
Visit Found ↗Editorial — no commercial relationship.
- Semaglutide
- $129/mo
- Tirzepatide
- $129/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
Price transparency88/100
State access96/100
Molecule range82/100
Onboarding speed74/100
Support responsiveness76/100
Licensing & trust74/100
What the Desk likes
- Identical low pricing on both molecules
- Nationwide 50-state access
- Strong coaching program
Where points come off
- Coaching subscription model isn't for everyone
- Compounded only
The Desk's briefing — C+
Best for: People who want behavior-change coaching tightly bundled with their medication.
Pricing and verification reflect Found's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Found's site. Not medical advice; see our disclosure.